Remdesivir News and Research

RSS
Challenges, unmet needs and future opportunities in COVID-19 therapeutics

Challenges, unmet needs and future opportunities in COVID-19 therapeutics

10 Apr 2022
Study explores broad-spectrum, host-acting antiviral strategy to treat SARS-CoV-2

Study explores broad-spectrum, host-acting antiviral strategy to treat SARS-CoV-2

7 Apr 2022
Value of information analysis on clinical trial data to help approve or reject new COVID-19 drugs

Value of information analysis on clinical trial data to help approve or reject new COVID-19 drugs

4 Apr 2022
Research demonstrates potential of local siRNA delivery as COVID antiviral therapy in the lung

Research demonstrates potential of local siRNA delivery as COVID antiviral therapy in the lung

3 Apr 2022
An in-depth analysis of pathogenesis of SARS-CoV-2 and therapeutic options for COVID-19

An in-depth analysis of pathogenesis of SARS-CoV-2 and therapeutic options for COVID-19

3 Apr 2022
Study explores molecular mechanisms underlying SARS-CoV-2 infection of macrophages and the induction of pro-inflammatory cytokines

Study explores molecular mechanisms underlying SARS-CoV-2 infection of macrophages and the induction of pro-inflammatory cytokines

1 Apr 2022
Impact of racial disparities on COVID-19 outcomes

Impact of racial disparities on COVID-19 outcomes

31 Mar 2022
Chemical in leafy greens could prevent infections by coronaviruses including SARS-CoV-2

Chemical in leafy greens could prevent infections by coronaviruses including SARS-CoV-2

30 Mar 2022
The potential efficacy of nasal nanoparticle COVID-19 vaccines

The potential efficacy of nasal nanoparticle COVID-19 vaccines

30 Mar 2022
Black patients with cancer experience worse outcomes after COVID-19 diagnosis

Black patients with cancer experience worse outcomes after COVID-19 diagnosis

28 Mar 2022
Scientists identify a promising strategy for stopping Ebola virus polymerase

Scientists identify a promising strategy for stopping Ebola virus polymerase

23 Mar 2022
Oral version of remdesivir could extend its reach and benefits to COVID-19 patients

Oral version of remdesivir could extend its reach and benefits to COVID-19 patients

22 Mar 2022
CD63-expressing extracellular vesicles neutralize SARS-CoV-2 variants of concern

CD63-expressing extracellular vesicles neutralize SARS-CoV-2 variants of concern

22 Mar 2022
Early treatment of COVID-19 in high-risk children and adolescents infected with the Omicron variant of SARS-CoV-2

Early treatment of COVID-19 in high-risk children and adolescents infected with the Omicron variant of SARS-CoV-2

22 Mar 2022
Is COVID-19 on the verge of ending?

Is COVID-19 on the verge of ending?

21 Mar 2022
Study explores novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2

Study explores novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2

21 Mar 2022
In silico identification of novel curcumin derivatives as potential inhibitors against SARS-CoV-2 enzymes

In silico identification of novel curcumin derivatives as potential inhibitors against SARS-CoV-2 enzymes

16 Mar 2022
Novel targets to inhibit SARS-CoV-2 variants

Novel targets to inhibit SARS-CoV-2 variants

16 Mar 2022
SARS-CoV-2 infection model generated from human tonsil epithelial organoids

SARS-CoV-2 infection model generated from human tonsil epithelial organoids

15 Mar 2022
Aminoglycoside antibiotic geneticin shows selective antiviral effect against SARS-CoV-2

Aminoglycoside antibiotic geneticin shows selective antiviral effect against SARS-CoV-2

11 Mar 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback